Credit: Getty Images. A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. The role of beta-blockers after acute ...
For patients who present with essential hypertension and further symptoms of possible heart failure, it is important for physicians to consider and treat the patient's underlying disease. A ...
Alpha-1 adrenergic receptors (α1-ARs) are a subset of G protein-coupled receptors that play a pivotal role in cardiovascular homeostasis. While traditionally recognised for their involvement in ...
Empagliflozin reduces heart failure hospitalization risk in patients with acute myocardial infarction, irrespective of type 2 diabetes or chronic kidney disease status. The EMPACT-MI trial showed a 23 ...
Dr. Patrick Malecha (Medicine): A 69-year-old man with a history of myocardial infarction, ischemic cardiomyopathy, and an implantable cardioverter–defibrillator (ICD) was evaluated because of dyspnea ...
A newly identified circadian checkpoint shifts neutrophils into a protective night-like state, reducing inflammatory heart injury while preserving the body’s ability to fight infection. Study: A ...
EMPACT-MI trial (EMPAgliflozin for the prevention of Chronic heart failure and morTality after an acute Myocardial Infarction, NCT04509674) is a multicenter, randomized, parallel-group, double-blind, ...
The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason. In the ABYSS ...
The medications may help prevent further tissue damage after a heart attack (myocardial infarction), according to a new study ...
Hosted on MSN
Developing a novel drug for acute myocardial infarction, acute kidney injury and subsequent chronic organ failure
Acute myocardial infarction and acute kidney injury are life-threatening conditions caused by ischemia, resulting from reduced or blocked blood flow to organs. Although early restoration of blood flow ...
Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results